| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.8 | $0-$5k | 0.00 |
Summary
A vulnerability marked as critical has been reported in eVisitorPass. Affected by this issue is some unknown functionality of the component Fullscreen Handler. The manipulation leads to access control. This vulnerability is documented as CVE-2018-17493. It is possible to launch the attack on the physical device. Additionally, an exploit exists.
Details
A vulnerability was found in eVisitorPass (the affected version is unknown) and classified as critical. This issue affects an unknown code of the component Fullscreen Handler. The manipulation with an unknown input leads to a access control vulnerability. Using CWE to declare the problem leads to CWE-264. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
eVisitorPass could allow a local attacker to gain elevated privileges on the system, caused by an error with the Fullscreen button. By visiting the kiosk and clicking the full screen button in the bottom right, an attacker could exploit this vulnerability to close the program and launch other processes on the system.
The bug was discovered 03/04/2019. The weakness was released 03/21/2019 (Website). It is possible to read the advisory at exchange.xforce.ibmcloud.com. The identification of this vulnerability is CVE-2018-17493 since 09/25/2018. Attacking locally is a requirement. No form of authentication is needed for a successful exploitation. Technical details are unknown but a public exploit is available. The attack technique deployed by this issue is T1068 according to MITRE ATT&CK.
It is declared as proof-of-concept. The vulnerability was handled as a non-public zero-day exploit for at least 17 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Entries connected to this vulnerability are available at VDB-131895, VDB-131894, VDB-131893 and VDB-131892. Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Name
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.8VulDB Meta Temp Score: 6.8
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.8
NVD Vector: 🔍
CNA Base Score: 8.4
CNA Vector (IBM Corporation): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Access controlCWE: CWE-264
CAPEC: 🔍
ATT&CK: 🔍
Physical: Yes
Local: Yes
Remote: No
Availability: 🔍
Access: Public
Status: Proof-of-Concept
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
09/25/2018 🔍03/04/2019 🔍
03/21/2019 🔍
03/22/2019 🔍
08/03/2023 🔍
Sources
Advisory: exchange.xforce.ibmcloud.comStatus: Not defined
CVE: CVE-2018-17493 (🔍)
GCVE (CVE): GCVE-0-2018-17493
GCVE (VulDB): GCVE-100-131891
X-Force: 149653
scip Labs: https://www.scip.ch/en/?labs.20161013
See also: 🔍
Entry
Created: 03/22/2019 07:02Updated: 08/03/2023 10:00
Changes: 03/22/2019 07:02 (56), 05/17/2020 17:10 (1), 08/03/2023 09:59 (4), 08/03/2023 10:00 (12)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.